Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cyclacel Pharmaceuticals Inc

+ Add to Watchlist

CYCC:US

1.6900 USD 0.1900 12.67%

As of 20:10:00 ET on 03/02/2015.

Company Profile for Cyclacel Pharmaceuticals Inc (CYCC)

Cyclacel Pharmaceuticals Inc. discovers and develops small molecule cycle inhibitors for the treatment of cancer and other serious diseases.

Contact Information

Cyclacel Pharmaceuticals Inc

200 Connell Drive #1500
Berkeley Heights, NJ 07922
United States
Phone: 1-908-517-7330
Fax: 1-866-271-3466

Key Executives for Cyclacel Pharmaceuticals Inc (CYCC)

Spiro G RombotisPresident/CEOPaul McBarronExec VP:Finance/CFO/COO/Secy
Judy ChiaoVP:Clinical Dev & Reg Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil